|
|
|
|
|
|
Bellicum Pharma Comm (BLCM)
|
|
7.8108 -0.0992 (-1.2541%)
|
8/17/2017 11:18am
|
|
Open:
|
7.8500
|
Pre. Close:
|
7.9100
|
|
High:
|
7.9700
|
Low:
|
7.6110
|
|
Volume:
|
184,813
|
Market Cap:
|
259.52M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
8.29 - 8.45
|
8.45 - 8.62
|
|
Low:
|
7.38 - 7.51
|
7.51 - 7.64
|
|
Close:
|
7.68 - 7.91
|
7.91 - 8.15
|
|
|
|
|
|
|
Technical analysis (as of: 2017-08-17 11:16:58 AM)
|
|
Overall:
|
 
|
|
Stoxline rating system posted a NEUTRAL today, downgraded from higher rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 12.23 One year: 14.44
|
|
Support:
|
Support1: 7.41 Support2: 6.17
|
|
Resistance:
|
Resistance1:
10.47 Resistance2: 12.36
|
|
Pivot:
|
9.31
|
|
Moving Averages:
|
MA(5): 7.77  MA(20): 9.95
MA(100): 11.83 MA(250): 14.43
|
|
MACD:
|
MACD(12,26):
-1.07 Signal(12,26,9): -0.82
|
|
%K %D:
|
%K(14,3): 8.39 %D(3): 6.66
|
|
RSI:
|
RSI(14): 28.11
|
|
52-Week:
|
High: 23.1100
Low: 7.4100 Change(%): -57.2
|
|
Average Vol(K):
|
3-Month: 69758
10-Days 54919
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.BLCM has closed above bottom band by 22.3%. Bollinger Bands are 89.3% wider than normal. The large width of the bands suggest high volatility as compared to BLCM's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.
|
|
|
Headline News
|
|
Wed, 29 Mar 2017 12:33:45 GMT
Is Bellicum Pharmaceuticals or Kite Pharma the better adoptive T-cell therapy ...
Thu, 17 Aug 2017 12:00:00 GMT
Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) Announces Gregory Naeve As Chief ...
Wed, 16 Aug 2017 13:18:45 GMT
Advanced Earnings Option Trade in Bellicum Pharmaceuticals Inc
Wed, 16 Aug 2017 17:26:15 GMT
stock Alert -: Bellicum Pharmaceuticals, Inc. (BLCM)
Tue, 15 Aug 2017 20:15:00 GMT
Bellicum Pharma (BLCM) Enters Cancer Research Grant Contract with CPRIT
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
